Rousselot Biomedical announces the world’s first GelMA produced under GMP

/ Rousselot®, Darling Ingredients’ health brand, and the global leader of collagen-based solutions announces the launch of GMP grade GelMA. X-Pure® GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions.

BigOmics closes Pre-Series A with additional investment from Eppendorf

BigOmics Analytics, a Swiss biodata analytics startup, announces raising additional funding from Eppendorf, a leading life science company that develops and sells instruments, consumables and services for liquid, sample and cell handling in laboratories worldwide. The additional funding brings the total amount raised so far to CHF 2.7M. It will be used to further develop BigOmics’ platforms, to expand its team and to grow its presence in the market.

TGen Selects MemVerge to Accelerate Idiopathic Pulmonary Fibrosis Research Discovery with Big Memory Technology

Translational Genomics Research Institute (TGen), an affiliate of City of Hope, is using MemVerge Memory Machine Big Memory virtualization software to accelerate time to discovery for Idiopathic Pulmonary Fibrosis (IPF), a disease which affects 100,000 people annually in the U.S. Using MemVerge Big Memory technology, TGen is able to dramatically speed analytical processing by nearly 36% for single-cell RNA sequencing.

Alfa Chemistry Optimizes Supply of Glycerides: Monoglycerides, Diglycerides, Triglycerides

Ever since the launch of a wide range of glycerides in the first quarter of last year, there are increasing in-coming demands for glycerides from clients across the globe. To improve user experience, Alfa Chemistry announces to upgrade and optimize this product line by further diversifying the supply of different types of glycerides, including monoglycerides, diglycerides, triglycerides.

CD Formulation Launches Tailed Solutions for Increased Bioavailability Excipients

In a recent statement, the York-based CRO company CD Formulation announces the launch of tailored solutions for increased bioavailability excipients, which aims to tackle the issue of poor bioavailability, a long-lasting challenge in drug development.

Newly Updated: Alfa Chemistry Introduces Environmental Standards to Achieve Fast and Accurate Environmental Analysis

Famed as a supplier of varieties of analytical reagents, Alfa Chemistry never let its customers down and always put customers’ concerns and needs in the first place. Hence, the company recently introduces environmental standards, which is a step to further diversify its offering of chromatography standards and also in response to the increasing needs for environmental analysis.

Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model

Canopy Launches Out of Stealth With $13 Million to Help Oncology Practices Adopt a Proactive Care Delivery Model

Oncology Pharma Company Announces Launch of Equity Crowdfunding Campaign

SciTech Development LLC, an oncology pharmaceuticals company, is pleased to announce its equity crowdfunding campaign on StartEngine.

MicrobioSeq Releases Microbial Transcriptomics for Disease Research and Drug Development

MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics is a genomics service company with a good reputation for providing reliable de novo sequencing, genotyping, microarray, and bioinformatics services. With years of experience in the pharmaceutical and life science sectors, CD Genomics has announced Microbial Transcriptomics solutions, which hold promise in uncovering novel ways to treat disease and improve human health.

Ultralow Input RNA-Seq Service Now Available by CD Genomics RNA Solutions Platform

RNA Solutions is a platform that offers services for the revolutionizing study of RNA, targeting both coding and non-coding RNAs of different physiological functions. The scientists at CD Genomics are ready to help detect various types of RNA via meticulous and integrative approaches. CD Genomics is proud to launch the ultralow input RNA-seq service using leading-edge Illumina sequencing techniques.

VisualDx Celebrates One Year of Project IMPACT at AAD

UCare Selects HealthSparq to Power Price Transparency for Individuals and Families

STEMart Introduces Acute Systemic Toxicity Testing Service for Medical Devices

STEMart launches Acute Systemic Toxicity testing for the medical device industry.

Amerigo Scientific Introduces the Launch of Polystreptavidin 350

Amerigo Scientific introduces Polystreptavidin 350 for applications in lateral flow, ELISA or CLIA.

CD BioSciences Introduces Genetic Polymorphism Services for GPCRs Study

CD BioSciences introduces a series of Genetic Polymorphism services for the study of GPCR polymorphisms.

Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA

-Absci to present in-silico drug discovery technology at NVIDIA GTC -Breakthrough ML achievements highlight the viability of the computational lead optimization pipeline -Absci collaborates with NVIDIA on research to accelerate and scale in-silico drug discovery platform

Integrated DNA Technologies Adds MLL Munich Leukemia Laboratory to Align Program

Qlucore participates at Redeye Theme Digital Health

Qlucore, listed on Nasdaq First North, participates on Redeye Theme Digital Health Day. CEO, Carl-Johan Ivarsson, presents the company at 09:30 and participates in the panel afterwards.

CD ComputaBio Announces PD-L1 Targeting Service for Anticancer Drug Research

BOC Sciences Optimizes PROTAC Platform to Boost Related Research

BOC Sciences optimizes its PROTAC platform of protein degradation technology to boost PROTAC research and development.